The GLP-1 telehealth market has two extremes that get most of the attention: ultra-budget providers under $100/month and premium brand-name options at $300+/month. But the real competition — and where most patients end up — is the mid-tier: providers charging $150–$300/month for compounded GLP-1 medications with varying levels of clinical support, flexibility, and add-on services.
This is where the decision gets harder, because the price differences are smaller and the differentiators are more subtle. Three providers exemplify distinct mid-tier strategies: Embody (clinical depth), Care Bare Rx (pricing simplicity), and Yucca Health (bundle value).
Embody's positioning is clear: pay slightly more, get meaningfully more clinical oversight. The $149 first-month price gets you through the door affordably, and the $299/month ongoing rate includes a dedicated provider relationship, structured titration management, and dosing adjustments based on your individual response. Their focus on injectable semaglutide means you're getting the highest-bioavailability format, not experimental oral formulations.
Best for: Patients who want a provider actively managing their treatment — especially those with comorbidities, medication interactions, or previous difficulty with GLP-1 side effects. First-time GLP-1 patients who want hand-holding during titration.
Trade-off: Higher ongoing monthly cost than stripped-down competitors. The clinical infrastructure costs more to operate, and that's reflected in pricing.
Pricing: $149 first month, $299/mo ongoing
Medications: Compounded injectable semaglutide
Injectable semaglutide only — custom treatment plans with ongoing clinical support.
Visit Embody → Paid linkCompounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs.
Care Bare Rx has carved a niche with one powerful promise: same price at every dose. In a market where most providers increase pricing as you titrate up — sometimes doubling the cost at higher doses — Care Bare's predictable pricing eliminates the "how much will this cost at 2.5mg?" anxiety. What you pay at the starting dose is what you pay at the maintenance dose.
Best for: Patients who prioritize budget predictability. If you've been burned by dose-escalation price jumps at other providers, or you want to know your exact monthly cost for the next 12 months, Care Bare's model removes that variable entirely.
Trade-off: The clinical model is less provider-intensive than Embody's. You'll have access to prescribing providers, but the relationship is more transactional than consultative.
Pricing: From $199/mo
Medications: Compounded semaglutide
Straightforward compounded semaglutide with same-price-at-every-dose commitment.
Visit Care Bare Rx → Paid linkCompounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs.
Yucca takes a different approach: reward commitment with lower per-month pricing. Their 6-month semaglutide bundle at $146/month and tirzepatide bundle at $258/month undercut most mid-tier competitors — but you're paying for multiple months upfront. The onboarding call with your provider adds a personal touch that most budget and mid-tier platforms skip.
Best for: Patients who are confident they'll continue treatment for at least six months and want the lowest per-month cost at the mid-tier quality level. The onboarding call is especially valuable for patients starting their first GLP-1.
Trade-off: Less flexibility than month-to-month programs. If you need to stop after two months, you've overpaid compared to a monthly provider. The bundle model requires confidence in your commitment.
Pricing: $258/mo tirzepatide, $146/mo semaglutide (6-mo bundles)
Medications: Compounded semaglutide & tirzepatide
Flexible plan lengths with discounted bundles and an actual onboarding call with your provider.
Visit Yucca Health → Paid linkCompounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs.
On pricing transparency: Care Bare Rx wins this category outright. Their same-price-at-every-dose model is the most transparent pricing structure in the GLP-1 market. Yucca is transparent about bundle pricing but the commitment aspect adds complexity. Embody is transparent about first-month and ongoing rates, but the jump from $149 to $299 requires patients to plan for the increase.
On clinical support: Embody leads. The dedicated provider relationship and structured titration protocol represent a genuinely different clinical experience from form-and-ship models. Yucca's onboarding call is a differentiator at this price tier. Care Bare offers clinical access but with a lighter-touch model.
On flexibility: Care Bare Rx's month-to-month model with straightforward cancellation gives patients the most control. Embody also operates month-to-month after the first month. Yucca's bundle pricing trades flexibility for savings — by design.
On medication options: Yucca offers both semaglutide and tirzepatide with transparent pricing for each. Embody focuses on injectable semaglutide. Care Bare specializes in compounded semaglutide. If tirzepatide access is important, Yucca has the advantage.
Choose based on what matters most to you:
| Provider | Starting Price | Medications | |
|---|---|---|---|
| Wellorithm | Check provider | Compounded GLP-1 medications | Visit → Paid link |
| Oak Weight Loss | Check provider | Compounded semaglutide & tirzepatide | Visit → Paid link |
| FeelGood Telehealth | Check provider | Compounded GLP-1 medications | Visit → Paid link |
| YourEra Health | Check provider | Compounded GLP-1 medications | Visit → Paid link |
| Direct Meds | Check provider | Compounded GLP-1 medications | Visit → Paid link |
| Found Health | From $129/mo (medication extra) | Compounded & brand-name GLP-1 options | Visit → Paid link |
Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. All provider links are paid affiliate links.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication. Compare GLP-1 is an independent comparison site not affiliated with any pharmaceutical manufacturer, telehealth provider, or government agency.
Affiliate Disclosure: We may earn a commission when you sign up through links on this page, at no additional cost to you. This helps support our independent research. All provider links marked "Paid link" are affiliate links.